NBoc-DMT
Pharmaceutical compound
From Wikipedia, the free encyclopedia
NBoc-DMT, or NB-DMT, also known as N1-tert-butoxycarbonyl-N,N-dimethyltryptamine, is a serotonergic psychedelic of the tryptamine family.[1][2] It is a novel designer and recreational drug and is a synthetic modification of dimethyltryptamine (DMT) with an N′-tert-butyloxycarbonyl (NBoc) group.[1][2]
- Illegal in Russia
| Clinical data | |
|---|---|
| Other names | NB-DMT; DMT-BOC; N′-t-BOC-DMT; N′-tert-BOC-DMT; tert-BOC-DMT; N′-tert-Butoxycarbonyl-N,N-dimethyltryptamine |
| Drug class | Serotonergic psychedelic; Hallucinogen; Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C17H24N2O2 |
| Molar mass | 288.391 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
NB-DMT is said to be a "prodrug" of DMT that decomposes into DMT when the compound is heated (e.g., with smoking or vaping).[1] It may also be useful as an orally active prodrug of DMT, unlike DMT itself which is inactive when taken orally.[3][4] NB-DMT has been claimed to have about 25% of the potency of DMT by weight.[1] It was first detected as a designer drug being sold online by February 2024.[1]
NB-DMT is a Schedule I controlled substance in Russia.[1] The drug is not an explicitly controlled substance in the United States[5] or in Canada.[6] A number of other NBoc designer drugs have also been encountered.[1][7]